About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch

Biovault Technical

About
Biovault Technical
Our Mission
Our Team
Facilities
Biovault Family
Quality
Accreditations
Advisory Board
Partnerships
Testimonials
Services
Cellular Therapy Processing
Biobanking
Allografts
Support services
Consultancy
Contingency Planning & Business Continuity
Insights
All
Cellular Therapies
Company News
Educational Resources
Ethical Approach
Industry Events
Innovation
Quality & Safety
Regulatory Compliance
Sustainability
Get in touch
1 December 2025
Cellular Therapies
Sarah Conway
Peripheral Blood Stem Cells, Understanding the ...

How peripheral blood stem cells became the preferred source for transplantation, and how Biovault supports PBSC collection pathways through compliant processing and storage.

Peripheral Blood Stem Cells, Understanding the Clinical Shift from Bone Marrow to PBSC
29 September 2025
Innovation
Sarah Conway
Engineering Cellular Therapy Tools: How ...

How Biovault Technical engineered new cryoshipper racks and CRF freezer racks to enhance safety, usability and compliance for cellular therapies.

Engineering Cellular Therapy Tools: How Biovault Built Better Cryo Racks
5 August 2025
Sustainability, Innovation, Ethical Practices
Sarah Conway
Biovault Halves Emissions in Under Five Years ...

As the UK’s ethical bioresource, Biovault is leading the way in slashing processing and storage emissions as part of its pledge to achieve Net Zero.

Biovault Halves Emissions in Under Five Years on Road to Net Zero
8 July 2025
Quality & Safety
Sarah Conway
Cryogenic Confusion: How terminology and ...

Clarify cold storage confusion. Learn how to define, map, and monitor temperature ranges accurately across cryogenic and controlled environments.

Cryogenic Confusion: How terminology and tolerance can jeopardise biological samples
13 May 2025
Industry Events, Company News, Cellular Therapies
Sarah Conway
What EBMT 2025 Told Us About the Future of Cell ...

Key insights from EBMT 2025, including trends in CAR-T, JACIE developments, and the growing demand for contingency services in cell therapy. Read Biovault’s perspective on what’s shaping the future of the field.

What EBMT 2025 Told Us About the Future of Cell Therapy
Sarah Conway
25 October 2024
Company News, Innovation

Redefining our bioresourceful business

Sarah Conway
25 October 2024
Company News, Innovation
Redefining our bioresourceful business

Biovault is more than a biobank. We are a bioresource offering stem cell processing, allografts, support services and consultancy, as well as biobanking you can trust.

Sarah Conway
9 September 2024
Cellular Therapies, Innovation

Lab-grown HSCs expand the future of cell therapy, and biobanking

Sarah Conway
9 September 2024
Cellular Therapies, Innovation
Lab-grown HSCs expand the future of cell therapy, and biobanking

Lab-grown stem cells may revolutionise cancer treatment by reducing the need for donors. What does this mean for bioresources like Biovault? 

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources

Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

Sarah Conway
23 July 2024
Ethical Practices, Innovation, Sustainability, Educational Resources
Biovault Reduces, Reuses, Recycles and Inspires in Bid to Combat Plastics & Waste

The UK healthcare sector produces hundreds of thousands of tonnes of waste every year. At Biovault, we’re working to reduce waste in every area and have been inspired by the difference it makes.

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies

EBMT Round up: 5 Key Takeaways from Glasgow 2024

Sarah Conway
29 May 2024
Industry Events, Company News, Cellular Therapies
EBMT Round up: 5 Key Takeaways from Glasgow 2024

EBMT 2024 was an inspiring event combining a patient-first ethos with insights from cellular therapy pioneers. We share our Top 5 Takeaways.

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships

Preventing catastrophic failure in biobank systems

Sarah Conway
22 April 2024
Quality & Safety, Regulatory Partnerships
Preventing catastrophic failure in biobank systems

Following the publication of a report on the devastating cryogenic freezer failure at the Karolinska Institutet (KI) in Sweden in December 2023, we scrutinise our systems and offer some support. 

Sarah Conway
13 March 2024
Cellular Therapies, Quality & Safety, Company News

Elevating Patient Care: Biovault's Expertise in Peripheral Blood Stem Cell (PBSC) Solutions

Sarah Conway
13 March 2024
Cellular Therapies, Quality & Safety, Company News
Elevating Patient Care: Biovault's Expertise in Peripheral Blood Stem Cell (PBSC) Solutions

In 2023, Biovault worked alongside 6 NHS trusts to process 1,552 cellular therapy products and to release 753, making us a leading provider of PBSC services.

Newer Posts
Older Posts
Back to Top
Biovault Technical Ltd, Plymouth International Medical & Technology Park, 24 Brest Road, Derriford, Plymouth, PL6 5XP, United Kingdom+44 1752 753720info@biovaulttechnical.co.uk

address

Biovault Technical
24 Brest Road
Plymouth, PL6 5XP
View on map

TELEPHONE

+44 (0)1752 753720

enquiries

info@biovaulttechnical.co.uk

careers

COOKIE POLICY

Privacy Policy

CONTACT